Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
- Status
- TERMINATED
- Phase
- PHASE2
A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
- Status
- COMPLETED
- Phase
- PHASE2
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
- Status
- COMPLETED
- Phase
- NA
Bevacizumab and Carboplatin for Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
- Status
- COMPLETED
- Phase
- PHASE2
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE3